|[February 18, 2013]
Research and Markets: Vasomotor Symptoms of Menopause - Pipeline Review, H2 2012 Features Players Such as Pfizer Inc. and Noven Pharmaceuticals, Inc.
DUBLIN --(Business Wire)--
Research and Markets (http://www.researchandmarkets.com/research/8f9vgv/vasomotor)
has announced the addition of Global Markets Direct's new report
"Vasomotor Symptoms of Menopause - Pipeline Review, H2 2012" to their
Global Markets Direct's 'Vasomotor Symptoms of Menopause - Pipeline
Review, H2 2012' provides an overview of the indication's therapeutic
pipeline. This report provides information on the therapeutic
development for Vasomotor Symptoms of Menopause, complete with latest
updates, and special features on late-stage and discontinued projects.
It also reviews key players involved in the therapeutic development for
Vasomotor Symptoms of Menopause. Vasomotor Symptoms of Menopause -
Pipeline eview, Half Year is built using data and information sourced
from Global Markets Direct's proprietary databases, Company/University
websites, SEC (News - Alert) filings, investor presentations and featured press
releases from company/university sites and industry-specific third party
sources, put together by Global Markets Direct's team.
- A snapshot of the global therapeutic scenario for Vasomotor Symptoms
- A review of the Vasomotor Symptoms of Menopause products under
development by companies and universities/research institutes based on
information derived from company and industry-specific sources.
- Coverage of products based on various stages of development ranging
from discovery till registration stages.
- A feature on pipeline projects on the basis of monotherapy and
- Coverage of the Vasomotor Symptoms of Menopause pipeline on the basis
of route of administration and molecule type.
- Key discontinued pipeline projects.
- Latest news and deals relating to the products.
Noven Pharmaceuticals, Inc.
Pantarhei Bioscience BV
Ausio Pharmaceuticals, LLC
For more information visit http://www.researchandmarkets.com/research/8f9vgv/vasomotor
Source (News - Alert): Global Markets Direct
[ Back To Technology News's Homepage ]